Prognostic factors in prostate carcinoma;Prognosefaktoren des Prostatakarzinoms

Pathologe

Volumn 19, Issue 1, 1998, Pages 42-52

  Helpap, B ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Institut fur Pathologie   (Germany)

Author keywords

Cell proliferation; Grading; Molecular pathology; Prognostic factors; Prostatic carcinoma

Indexed keywords

CANCER GRADING; CANCER RISK; CELL PROLIFERATION; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; PROGNOSIS; PROSTATE CARCINOMA; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; BIOPSY, NEEDLE; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031936695     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050253     Document Type: Review

References (67)

1. Bigler SA, Deering RE, Brawer MK (1993) Comparison of microscopic vascutarity in benign and malignant prostate tissue. Hum Pathol 24:220-226
2. Bocking A (1992) Diagnostic DNA-cytometry of prostatic cancer. Dign Oncol 2:90-96
3. Böcking A, Sommerkamp P (1981) Histologisches Malignitätsgrading des Prostatacarcinoms. Prognostische Validität, Reproduzierbarkeit und Repräsentativität. Verh Dtsch Ges Urol 32:63-65
4. Bocking A, Kiehn J, Heinzel-Wache M (1982) Combined histologic grading of prostatic carcinoma. Cancer 40:288-294
5. Bocking A, Helpap B, Muller HA, Kastendieck H (1984) Zytologisches Regressionsgrading des ProstataCarcinoms.Verh Dtsch Ges Path 68 399
6. Böcking A, Auffermann W, Jocham D, Contractor H, Wohltmann D (1985) DNA-grading of malignancy and tumor regression in prostatic carcinoma under hormone therapy. Appl Pathol 3:206-214
7. Bocking A, Chaterlain R, Orthen U, Gien G, Kalckreuth von G, Jocham D (1988) DNA-grading of prostatic carcinoma: prognostic validity and reproducibility. Anticancer Res 8:129-136
8. Bonkhoff H (1997) Histogenesis of normal and abnormal prostatic growth. In: Helpap B (ed) The prostate. Benign prostatic hyperplasia and carcinoma. Actual positions and future perspectives Thieme, Stuttgart
9. Bonkhoff H, Remberger K (1996) Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28, 2:98-106
10. Bonkhoff H, Remberger K (1995) Morphogenetic aspects of normal and abnormal prostatic growth. Pathol Res Pract 191:833-835
11. Bonkhoff H, Stein U, Remberger K (1995) Endocrine-paracrine cells types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol 26:167-170
12. Bostwick DG (1997) Neoplasm of the prostate. In: Bostwick DG, Eble JN (eds) Urologic surgical pathology. Mosby, St Louis Baltimore Boston, pp 343-422
13. Brawer M, Deering R, Brown M, Preston S, Bigler S (1994) Predictors of pathological stage in prostatic cancer. The role of neovascularity. Cancer 73:678-687
14. Brawn PN, Ayala AG, von Eschenbach AC, Hussey DH, Johnson DE (1982) Histologic grading study of prostate adenocarcinoma: the development of a new system and comparison with other methods - a preliminary study. Cancer 49:525-532
15. Bubendorf L, Sauter G, Moch H, Jordan R Blochlinger A, Gasser TC, Mihatsch MJ (1996) Prognostic significance of bcl2 in clinically localized prostate cancer. Am J Pathol 148:1557-1567
16. Bubendorf L, Sauter G, Moch H, Schmidt HP, Gasser TC, Jordan P, Mihatsch MJ (1996) Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy. J Pathol 178 437-441
17. Chiusa L, Galliano D, Formiconi A, Di Primio O, Pich A (1997) High and low risk prostate carcinoma determined by histologic grade and proliferative activity. Cancer 79:1956-1963
18. Dhom (1977) Classification and grading of prostatic carcinoma. In:Grundmann E, Vahlensieck W (eds) Tumors of the male genital-system. Recent result in cancer research. Springer, Berlin Heidelberg New York
19. Dhom G (1981) Pathologie des Prostatacarcinoms. Verh Ges Urol 39:9-16
20. Dhom G (1992) Prostata. In: Doerr W, Seifert G (Hrsg) Pathologie des männlichen Genitale Spezielle pathologische Anatomie, Bd 21. Springer, Berlin Heidelberg New York, S 455-642
21. Dhom G, Drego S (1982) Therapy of prostatic cancer and histopathologic follow-up. Prostate 3:531-542
22. Epstein JI (1994) The prostate and seminal vesicles. In:Sternberg SS (ed) Diagnostic surgical pathology. Raven, New York, pp 1807-1853
23. Epstein JI (1995) Prostate biopsy interpretation, 2nd ed. Lippincott-Raven, Philadelphia
24. Epstein JI (1995) Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol 26:223-229
25. Epstein IJ, Partin AW, Sauvageot J, Walsh PC (1996) Prediction of progression following radical prostatectomy. A multivariante analysis of 721 men with long term follow-up. Am J Surg Pathol 20:283-292
26. Gleason DF, Mellinger GT and the Veterans Administration Cooperative Urological Research Group (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58-64
27. Harada M, Mostofi FK, Corle DK, Byar DP, Trump BF (1977) Preliminary studies of histological prognosis in cancer of the prostate. Cancer Treat Rep 61:223-225
28. Hanke P, Schneider M, Gotting B, Jonas D (1988) Prognose und Beurteilung von Prostatacarcinomen - ein Vergleich der Klassifikation nach Dhom und der kombinierten, histologisch-zytologischen Klassifikation des onkologischen Arbeitskreises Prostatakarzinom. In: Helpap B, Senge T, VahlensieckW (Hrsg) Die Prostata, Bd 4: Prostataerkrankungen. PMI, Frankfurt/Main, S 130-135
29. Helpap B (1981) Cell kinetic and cytological grading of prostatic carcinoma. Virchows Arch [A] 393:205-214
30. Helpap B (1988) Frequency and localization of nucleoli in nuclei from prostatic carcinoma and atypical hyperplasia. Histopathology 12:203-211
31. Helpap B (1989) Pathologie der ableitenden Harnwege und der Prostata. Springer, Berlin Heidelberg New York
32. 32. Helpap B (1993) Review of the morphology of prostatic carcinoma with special emphasis of subgrading and prognosis. J Urol Pathol 1:3-19
33. Helpap B (1993) Atlas der Pathologie Urologischer Tumoren und Tumoren der Prostata. Springer, Berlin Heidelberg New York, S 105-160
34. Helpap B (1995) Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate. Pathol Res Pract 191:904-907
35. Helpap B (1998) The prostate. Benign prostatic hyperplasia and carcinoma. Actual positions and future perspectives. Thieme, Stuttgart
36. Helpap B, Koch V (1991) Histological and immunohistochemical findings of prostatic carcinoma after external or interstitial radiotherapy. J Cancer Res Clin Oncol 117:608-614
37. Helpap B, Oehler U, Köllermann J (1996) Erfahrungen aus dem Konsiliardienst für Prostataerkrankungen. Pathologe 17:417-424
38. Helpap B, Riede C (1995) Nucleolar und AgNOR-analyses of the prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH), and prostatic carcinoma. Pathol Res Pract 191 380-390
39. Helpap B, Böcking A, Dhom G, Faul P, Kastendieck H, Leistenschneider W, Müller HA (1985) Klassifikation, histologisches und zytologisches Grading sowie Regressionsgrading des ProstataCarcinoms. Eine Empfehlung des Pathologisch-Urologischen Arbeitskreises "ProstataCarcinom". Pathologe 6:3-7 und Urologe [A] 24:156-159
40. Helpap B, Böcking A, Dhom G, Faul P, Kastendieck H, Leistenschneider W, Müller HA (1985) Klassifikation, histologisches und zytologisches Grading sowie Regressionsgrading des ProstataCarcinoms. Eine Empfehlung des Pathologisch-Urologischen Arbeitskreises "ProstataCarcinom". Pathologe 6:3-7 und Urologe [A] 24:156-159
41. Helpap B, Bubendorf L, Oehler U, Sauter G (1997) Chromogranin-A-positive Tumoren der Prostata. Verh Dtsch Ges Pathol 81
42. 41a. Hermanek P, Sobin LH (1992) TNM-classification of malignant tumours, 4th ed. Springer Berlin Heidelberg New York, pp 141-143
43. 41b Sobin LH, Wittekind Ch (1997) TNM-classification of malignant tumours, 5th ed. Wiley-Liss New York Chichester Weinheim Brisbane Singapore Toronto, pp 172
44. Hofstadter F (1992) Grading of prostate carcinoma: In: Breul J, Hartung R (eds) Aktuelle Onkologie 78: Prognostic factors in urologic cancer. Proceedings of the first international symposium of prognostic factors in urologic cancer. München Zuckschwerdt, Munchen Berlin New York, pp 26-35
45. Montironi R, Diamanti L, Thompson D, Bartels HG, Bartels PH (1996) Analysis of the capillary architecture and the precursors of prostate cancer: recent findings and new concepts. Eur Urol 1996 30:191-200
46. Montironi R, Magi Galluzzi C, Diamanti L, Taborro R, Scarpelli M, Pisani E (1993) Prostatic intraepithelial neoplasia. Qualitative and quantitative analyses of the blood capillary architecture and thin tissue sections. Pathol Res Pract 189:542-548
47. Montironi R, Magi Galluzzi C, Fabris G (1995) Apoptotic bodies in prostatic intraepithelial neoplasia and prostatic adenocarcinoma following total androgen ablation. Pathol Res Pract 191:873-880
48. Montironi R, Pomante R, Diamanti L (1998) Proliferating cell nuclear antigen and apoptotic bodies in the precursors of untreated prostate cancer. In: Helpap B (ed) The prostate. Benign prostatic hyperplasia and carcinoma. Actual positions and future perspectives. Thieme, Stuttgart
49. Mostofi FK (1975) Grading of prostatic carcinoma. Cancer Ther Rep 59:111-117
50. Mostofi FK, Sesterhenn J, Sobin LH (1980) Histological typing of prostate tumours. International histological classification of tumours. NO. 22. World Health Organisation, Geneva
51. Müller HA, Altenahr E, Bocking A, Dhom G, Faul P, Göttinger H, Helpap B, Hohbach CH, Kastendieck H, Leistenschneider G (1980) Klassifikation und Grading des Prostatacarcinoms. Verh Dtsch Ges Pathol 64:609-611
52. Nativ O, Winkler HZ, Raz Y (1989) Stage C prostatic adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis. Mayo Clin Proc 64:911-919
53. Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics. CA 46:5-27
54. Schroeder FH, Mostofi FK, Belt F (1978) Malignitätsgrad und Prognose des Prostatacarcinoms. Verh Dtsch Krebsges 1:255-256
55. Schroeder FH, Blom JHM, Hop WCJ, Mostofi FK (1985) Grading of prostatic cancer (I). An analysis of the prognostic significance of single characteristics. Prostate 6:81-100
56. Schroeder FH, Hop WCJ, Blom JHM, Mostofi FK (1985) Grading of prostatic cancer (III). Multivariate analysis of prognostic parameters. Prostate 7:13-20
57. Seidl CH, Grouls V, Jellinghaus W (1997) Diagnostische Kriterien und prognostische Aussagen bei der histopathologischen Beurteilung von Stanzbiopsien der Prostata. Arztebl Rheinland-Pfalz 133-138
58. Shankey TV, Kallioniemi OP, Koslowski JM (1993) Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry 14:497-500
59. Silberman MA, Partin AW, Veltri RW, Epstein JI (1997) Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 79:772-779
60. Stiens R, Helpap B, Weißbach L (1981) Quantitative Untersuchungen zum Zellverlust in Prostatacarcinomen. Klinischmorphologische Aspekte. Verh Dtsch Ges Urol 32:73-74
61. Tribukait B (1993) Nuclear deoxyribouncleic acid determination in patient with prostatic carcinomas. Eur Urol 23:64-68
62. Zincke H, Bergstrahl EJ, Larson Keller JJ (1992) Stage 1 prostate cancer reated by radical prostatectomy and adjuvant hormonal treatment. Evidence of favorable survival in patients with DNA diploid tumors. Cancer 70 [Suppl]:311-323
63. Pantel K, Aignherr C, Köllermann J, Caprano J, Riethmuller G, Kollermann MW (1995) Immunohistochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer. Eur J Cancer 31A, 10:1627-1632
64. Köllermann J, Helpap B, Heseding B, Pantel K, Köllermann M (1997) Clinically localized prostate cancer: Immunohistochemistry on lymph nodes and bone marrow aspirates. Verh Dtsch Ges Pathol 81:487
65. Pelkey TJ, Frierson HF, Bruns DE (1996) Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42, 9:1369-1381
66. Pantel K, Riethmüller G (1995) Methods for detection of micrometastatic carcinoma cells in bone marrow, blood and lymph Nodes. Onkologie 18:394-401
67. Pantel K, Enzmann T, Köllermann J, Caprano J, Riethmuller G, Köllermann MW (1997) Immunocytochemical monitoring of micrometastatic disease: Reduction of prostate cancer cells in bone marrow by androgen deprivation. Int J Cancer 71:521-525